Detalhe da pesquisa
1.
Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Int J Gynecol Cancer;
18(4): 773-8, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-17892452
2.
Evaluation of tamoxifen in persistent or recurrent nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Int J Gynecol Cancer;
14(5): 871-4, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15361197
3.
Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study.
Gynecol Oncol;
83(2): 268-70, 2001 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-11606082
4.
Evaluation of recombinant human interleukin-12 in patients with recurrent or refractory ovarian cancer: a gynecologic oncology group study.
Gynecol Oncol;
82(1): 7-10, 2001 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-11426954
5.
A phase II trial of CI-958 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol;
81(3): 433-5, 2001 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-11371134
6.
A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Gynecol Oncol;
81(2): 213-5, 2001 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11354055
7.
A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group Study.
Invest New Drugs;
19(1): 77-80, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11291835
8.
Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: a Gynecologic Oncology Group Study.
J Clin Oncol;
19(5): 1275-8, 2001 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11230468
9.
Phase II trial of CI-958 in recurrent platinum-refractory ovarian carcinoma. A Gynecologic Oncology Group Study.
Gynecol Oncol;
79(3): 463-5, 2000 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-11104620
10.
Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Gynecol Oncol;
79(1): 64-6, 2000 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-11006033
11.
Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study.
Am J Clin Oncol;
23(4): 355-7, 2000 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-10955863
12.
Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.
Gynecol Oncol;
77(3): 446-9, 2000 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-10831357
13.
Phase II evaluation of 24-h continuous infusion topotecan in recurrent, potentially platinum-sensitive ovarian cancer: A Gynecologic Oncology Group study.
Gynecol Oncol;
77(1): 112-5, 2000 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-10739699
14.
Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: A Gynecologic Oncology Group Study.
J Clin Oncol;
18(5): 1062-7, 2000 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-10694558
15.
Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group.
Gynecol Oncol;
76(2): 204-7, 2000 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-10637071
16.
Lack of efficacy of 24-h infusional topotecan in platinum-refractory ovarian cancer: A Gynecologic Oncology Group trial.
Gynecol Oncol;
75(3): 444-6, 1999 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-10600304
17.
Dactinomycin in the treatment of recurrent or persistent endometrial carcinoma: A Phase II study of the Gynecologic Oncology Group.
Gynecol Oncol;
75(3): 473-5, 1999 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-10600310
18.
Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
J Clin Oncol;
17(9): 2676-80, 1999 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-10561341
19.
Phase II trial of paclitaxel in leiomyosarcoma of the uterus: a gynecologic oncology group study.
Gynecol Oncol;
74(3): 346-9, 1999 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-10479491
20.
Intraperitoneal alpha-interferon alternating with cisplatin in residual ovarian carcinoma: a phase II Gynecologic Oncology Group study.
Gynecol Oncol;
74(1): 48-52, 1999 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10385550